Exact Mass: 587.1791374000001
Exact Mass Matches: 587.1791374000001
Found 84 metabolites which its exact mass value is equals to given mass value 587.1791374000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Acetyl-D-glucosaminyldiphosphodolichol
C23H43NO12P2 (587.2260378000001)
This compound is an intermediate in N-glycan biosynthesis, and the byproduct of N-acetylglucosaminyldiphosphodolichol (EC 2.4.1.141) and UDP-N-acetylglucosamine-dolichyl-phosphate (EC 2.7.8.15). (KEGG) This compound and its corresponding enzymes are implicated in the developmental programmes of a variety of eukaryotes. (PMID: 10024536) [HMDB] This compound is an intermediate in N-glycan biosynthesis, and the byproduct of N-acetylglucosaminyldiphosphodolichol (EC 2.4.1.141) and UDP-N-acetylglucosamine-dolichyl-phosphate (EC 2.7.8.15). (KEGG) This compound and its corresponding enzymes are implicated in the developmental programmes of a variety of eukaryotes. (PMID: 10024536).
Barasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid
Quinoline, 6-(1-methyl-1-(methylsulfonyl)ethyl)-8-(3-((1E)-2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)ethenyl)phenyl)-
C31H29N3O5S2 (587.1548544000001)
3,10,11-triacetoxy-8beta-(4-acetoxybenzyl)-2-methoxyberbine|3,10,11-triacetoxy-8beta-<4-acetoxybenzyl>-2-methoxyberbine
Brominated Phosphatidylcholine C24H47BrNO8 - putative - Functions on the acyl moity have unknown location
Brominated Phosphatidylcholine mz 2+ C24H47BrNO8 - putative - Functions on the acyl moity have unknown location
Asp His Met Trp
Asp His Trp Met
Asp Met His Trp
Asp Met Trp His
Asp Gln Tyr Tyr
Asp Trp His Met
Asp Trp Met His
Asp Tyr Gln Tyr
Asp Tyr Tyr Gln
Glu Asn Tyr Tyr
Glu Tyr Asn Tyr
Glu Tyr Tyr Asn
His Asp Met Trp
His Asp Trp Met
His Met Asp Trp
His Met Trp Asp
His Trp Asp Met
His Trp Met Asp
Met Asp His Trp
Met Asp Trp His
Met His Asp Trp
Met His Trp Asp
Met Trp Asp His
Met Trp His Asp
Asn Glu Tyr Tyr
Asn Tyr Glu Tyr
Asn Tyr Tyr Glu
Gln Asp Tyr Tyr
Gln Tyr Asp Tyr
Gln Tyr Tyr Asp
Trp Asp His Met
Trp Asp Met His
Trp His Asp Met
Trp His Met Asp
Trp Met Asp His
Trp Met His Asp
Tyr Asp Gln Tyr
Tyr Asp Tyr Gln
Tyr Glu Asn Tyr
Tyr Glu Tyr Asn
Tyr Asn Glu Tyr
Tyr Asn Tyr Glu
Tyr Gln Asp Tyr
Tyr Gln Tyr Asp
Tyr Tyr Asp Gln
Tyr Tyr Glu Asn
Tyr Tyr Asn Glu
Tyr Tyr Gln Asp
N-Acetyl-D-glucosaminyldiphosphodolichol
C23H43NO12P2 (587.2260378000001)
Aurora A Inhibitor I
((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)METHYL)TRIPHENYLPHOSPHONIUM IODIDE
2-[Ethyl[3-[[4-[[1-[2-[(3-fluorophenyl)amino]-2-oxoethyl]-1H-pyrazol-4-yl]amino]quinazolin-7-yl]oxy]propyl]amino]ethyl dihydrogen phosphate
MK 0893
5-O-(4,4-Dimethoxytrityl)-N4-acetyl-2-deoxycytidine
C32H33N3O8 (587.2267538000001)
3-Hexadecyl-1-methyl-1H-imidazolium 1,1,1-Trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide
6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE
C31H29N3O5S2 (587.1548544000001)
Vestipitant Mesylate
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-YL)-1H-pyrazol-1-YL)ethyl)benzamido)propanoic acid
(Z)-8-(3-(2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)vinyl)phenyl)-6-(2-(methylsulfonyl)propan-2-yl)quinoline
C31H29N3O5S2 (587.1548544000001)
9-(Dimethylamino)-1-{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutyl}-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium perchlorate
C29H34ClN3O8 (587.2034314000001)
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
[3-hydroxy-2-[(Z)-16-(81Br)bromanyl-5-hydroxyhexadec-12-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[(Z)-16-(79Br)bromanyl-5-hydroxyhexadec-12-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
Barasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Phosphoramidon (Disodium)
C23H32N3Na2O10P (587.1620621999999)
Phosphoramidon Disodium, a microbial metabolite, is a specific metalloprotease thermolysin inhibitor with an IC50 of 0.4 μg/mL. Phosphoramidon Disodium also inhibits endothelin-converting enzyme (ECE), neutral endopeptidase (NEP), and angiotensin-converting enzyme (ACE) with IC50 values of 3.5, 0.034, and 78 μM, respectively[1][2][3].
17,18-dichloro-1,4,7,11-tetrahydroxy-3-(1-hydroxyethyl)-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
14,26-dihydroxy-2-[3-hydroxy-6-(hydroxymethyl)-4-oxopyran-2-yl]-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
C32H33N3O8 (587.2267538000001)
4-{[(5s)-8-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,5-dihydroxy-3-methyl-7,12-dioxo-5h-6-azatetraphen-6-yl]methyl}benzoic acid
C32H29NO10 (587.1791374000001)
(1r,2s,17s,19s)-14,26-dihydroxy-2-[3-hydroxy-6-(hydroxymethyl)-4-oxopyran-2-yl]-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
C32H33N3O8 (587.2267538000001)
(1s,4s,9s,10s,25s,26r)-4,22-dihydroxy-7-(hydroxymethyl)-17,17,24,24-tetramethyl-8,16-dioxa-3,22,28-triazanonacyclo[23.6.1.0¹,²⁸.0³,²⁶.0⁴,⁹.0¹⁰,²⁶.0¹¹,²³.0¹²,²¹.0¹⁵,²⁰]dotriaconta-6,11(23),12,14,18,20-hexaene-2,5,27-trione
C32H33N3O8 (587.2267538000001)
(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-1,4,7,11-tetrahydroxy-3-[(1r)-1-hydroxyethyl]-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
4,22-dihydroxy-7-(hydroxymethyl)-17,17,24,24-tetramethyl-8,16-dioxa-3,22,28-triazanonacyclo[23.6.1.0¹,²⁸.0³,²⁶.0⁴,⁹.0¹⁰,²⁶.0¹¹,²³.0¹²,²¹.0¹⁵,²⁰]dotriaconta-6,11(23),12,14,18,20-hexaene-2,5,27-trione
C32H33N3O8 (587.2267538000001)